Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.38 USD | +4.39% | +9.68% | -20.93% |
May. 06 | Omega Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 16 | Omega Therapeutics CFO Joshua Reed to Depart | MT |
Financials (USD)
Sales 2024 * | 4.45M | Sales 2025 * | 917K | Capitalization | 126M |
---|---|---|---|---|---|
Net income 2024 * | -77M | Net income 2025 * | -92M | EV / Sales 2024 * | -0.27 x |
Net cash position 2024 * | 127M | Net cash position 2025 * | 30.93M | EV / Sales 2025 * | 103 x |
P/E ratio 2024 * |
-1.88
x | P/E ratio 2025 * |
-1.96
x | Employees | 94 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.08% |
Latest transcript on Omega Therapeutics, Inc.
1 day | +4.39% | ||
1 week | +10.96% | ||
Current month | +6.73% | ||
1 month | -5.37% | ||
3 months | -44.00% | ||
6 months | +27.96% | ||
Current year | -20.93% |
Managers | Title | Age | Since |
---|---|---|---|
Mahesh Karande
CEO | Chief Executive Officer | 51 | 19-05-31 |
Joshua Reed
DFI | Director of Finance/CFO | 51 | 22-05-22 |
Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Luke Beshar
BRD | Director/Board Member | 65 | 21-04-30 |
John Mendlein
BRD | Director/Board Member | 64 | 19-12-31 |
Christian Schade
CHM | Chairman | 63 | 23-07-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +4.26% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 2.38 | +4.39% | 195,264 |
24-05-15 | 2.28 | -3.39% | 414,185 |
24-05-14 | 2.36 | +0.21% | 426,960 |
24-05-13 | 2.355 | +20.15% | 742,178 |
24-05-10 | 1.96 | -9.68% | 519,333 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.93% | 126M | |
+33.37% | 49.46B | |
+1.55% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.57% | 26.61B | |
-21.00% | 18.64B | |
+7.36% | 13.16B | |
+28.30% | 12.55B | |
+23.80% | 12.1B |
- Stock Market
- Equities
- OMGA Stock